Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for anesthesia maintenance and IONM compatibility in suboccipital tumor surgery
ChiCTR2600127857Phase 4Not yet recruiting
- Sponsor
- General Hospital of Central Theater Command of the Chinese People's Liberation Army
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in brain neoplasm (7 arms), sponsored by General Hospital of Central Theater Command of the Chinese People's Liberation Army. Primary endpoints: Latency and amplitude of sensory evoked potentials (SSEP), Latency and amplitude of motor evoked potentials (TcMEP) and 6 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on ChiCTR2600127857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127857.